For decades, ankylosing spondylitis was considered a man’s disease, but new research reveals something shocking: ankylosing spondylitis hits women differently and nearly as frequently as men, yet ...

Medical professional societies encourage development of treatment recommendations and/or guidelines that are based on current best evidence and represent a popular way of integrating evidence-based ...

"Women appear to have a different phenotype in AS [and] they are less likely to form syndesmophytes despite fused SI joints with at least 20 years of disease duration." --Ridley, et al., Journal of ...

Bimekizumab demonstrated safety and efficacy at 2 years among patients with nonradiographic axial spondyloarthritis (nr-axSpA) and ankylosing spondylitis (AS). Bimekizumab is currently FDA approved ...

It can be tough to live with a painful, lifelong condition like ankylosing spondylitis. You may have trouble working, or doing activities you’ve always enjoyed. You may feel like friends, family, and ...

Treatment for ankylosing spondylitis (AS) aims to achieve and maintain remission. When in remission, disease activity such as inflammation, joint stiffness, and pain is low or minimal. AS is a type of ...

Natural treatments for ankylosing spondylitis (AS), a type of inflammatory arthritis, can help you to deal with pain and stiffness in the spine and other joints. Exercise, nutrition, and smoking ...

(RTTNews) - UCB announced new long-term data from the Bimzelx (bimekizumab) Phase 2b study BE AGILE and its open-label extension. Patients with ankylosing spondylitis treated with Bimzelx, an IL-17A ...

How Does Chronic Treatment with Biologics Affect Efficacy of Systemic Antibiotics or Steroids for Acute HS Flares?